Hepatitis

In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. Researchers have discovered that cells blood vessels in the liver start a 'sleep timer' that switches off immune cells. Targeting this mechanism could be a starting point for immunotherapies. In chronic hepatitis B, the liver

A new study has found a startling disparity in the frequency of liver disease for transgender individuals and highlights the need for more specialized care. Cirrhosis is chronic, progressive end-stage liver disease that occurs when scar tissue prevents the liver from functioning normally. Studies have shown that two of the leading causes of cirrhosis --

Researchers have provided new insights into the lasting effects of chronic Hepatitis C virus (HCV) infection on the immune system, even after the disease has been successfully treated. The research team has discovered that traces of 'epigenetic scars' remain in regulatory T cells and exhibit sustained inflammatory properties long after the virus is cleared from

RNA into its own genome, allowing it to evade the immune system and resist treatment. This groundbreaking discovery sheds light on the mechanisms behind chronic Hepatitis E and paves the way for the development of more effective therapies. The study's findings have far-reaching implications for the understanding and management of Hepatitis E and other viral infections

Genetic material of the virus. This breakthrough discovery could lead to the development of a potential treatment for hepatitis E, offering hope for thousands of people at risk of the deadly disease. With its potential to save lives and revolutionize the treatment of hepatitis E, "K11777: A Promising Compound for Hepatitis E Treatment" is a game-changing post that highlights the importance of ongoing research in the field of virology